NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 194 filers reported holding NEVRO CORP in Q4 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $460,102 | -46.8% | 18,100 | -24.4% | 0.00% | -50.0% |
| Q1 2023 | $864,924 | +25.4% | 23,926 | +37.4% | 0.01% | +33.3% |
| Q4 2022 | $689,476 | -80.6% | 17,411 | -18.8% | 0.01% | -84.2% |
| Q2 2021 | $3,556,000 | +612.6% | 21,449 | +329.8% | 0.04% | +22.6% |
| Q1 2020 | $499,000 | +101.2% | 4,991 | +135.9% | 0.03% | +416.7% |
| Q4 2019 | $248,000 | -28.7% | 2,116 | -65.3% | 0.01% | -60.0% |
| Q3 2018 | $348,000 | -12.8% | 6,100 | +22.0% | 0.02% | -31.8% |
| Q2 2018 | $399,000 | -77.0% | 5,000 | -75.0% | 0.02% | -83.1% |
| Q1 2018 | $1,734,000 | -46.0% | 20,008 | -57.0% | 0.13% | -50.6% |
| Q4 2017 | $3,214,000 | +892.0% | 46,555 | +1207.7% | 0.26% | +776.7% |
| Q3 2017 | $324,000 | -79.2% | 3,560 | -83.0% | 0.03% | -81.2% |
| Q2 2017 | $1,556,000 | -53.5% | 20,906 | -54.6% | 0.16% | -63.0% |
| Q4 2016 | $3,345,000 | +1335.6% | 46,033 | +1966.1% | 0.43% | +982.5% |
| Q3 2016 | $233,000 | -38.7% | 2,228 | -67.0% | 0.04% | -74.2% |
| Q1 2016 | $380,000 | – | 6,742 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,776,368 | $34,141,793 | 1.08% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $66,424,320 | 1.02% |
| Palo Alto Investors LP | 386,832 | $7,434,911 | 0.70% |
| Rock Springs Capital Management LP | 1,211,600 | $23,286,952 | 0.62% |
| ArrowMark Colorado Holdings LLC | 2,468,110 | $47,437,074 | 0.58% |
| TD Capital Management LLC | 84,648 | $1,626,935 | 0.20% |
| Venator Management LLC | 25,000 | $480,500 | 0.18% |
| DAFNA Capital Management LLC | 28,000 | $538,160 | 0.17% |
| FRED ALGER MANAGEMENT, LLC | 1,053,812 | $20,254,266 | 0.12% |
| Counterpoint Mutual Funds LLC | 6,844 | $131,542 | 0.11% |